Literature DB >> 7418187

A method for estimation of circulating immune complexes after oral challenge with ovalbumin.

M Inganäs, S G Johansson, A Dannaeus.   

Abstract

Sera from forty-two children orally challenged with ovalbumin were analysed for the presence of IgG-ovalbumin immune complexes. The technique used is based on the absorption of the IgG of the complex to immobilized protein-A and detection of the ovalbumin of the complex on the solid phase, using isotope-labelled, pepsin-digested antibodies to ovalbumin. Children with high serum levels of antibody to ovalbumin had significantly higher concentrations of IgG-ovalbumin complexes that children with low antibody levels. In both groups the appearance of the complexes in the serum was accompanied by a significant decrease of the complement factor C3 (P < 0.05). The duration of the decrease in C3 was correlated to the amount of IgG-ovalbumin complexes, suggesting a consumption of C3 by these immune complexes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7418187     DOI: 10.1111/j.1365-2222.1980.tb02110.x

Source DB:  PubMed          Journal:  Clin Allergy        ISSN: 0009-9090


  4 in total

Review 1.  Diagnostic tests for food allergy.

Authors:  S L Bahna
Journal:  Clin Rev Allergy       Date:  1988

Review 2.  Interactions of food antigens, antibodies, and antigen-antibody complexes in health and disease.

Authors:  R Paganelli; P M Matricardi; F Aiuti
Journal:  Clin Rev Allergy       Date:  1984-02

3.  Detection of specific antigen within circulating immune complexes: validation of the assay and its application to food antigen-antibody complexes formed in healthy and food-allergic subjects.

Authors:  R Paganelli; R J Levinsky; D J Atherton
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

4.  Do food antigens play a role in the pathogenesis of some cases of human glomerulonephritis?

Authors:  F J van der Woude; P J Hoedemaeker; M van der Giessen; P A de Graeff; J de Monchy; T H The; G K van der Hem
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.